Logo

mergers & acquisitions

Precision for Medicine's QuartzBio Acquires Genomic Data Analytics Firm SolveBio

QuartzBio expects SolveBio's genomics and clinical data analytics technology to accelerate biomarker discovery in pursuit of precision therapies.

Inscripta Acquires Infinome Biosciences, Sestina Bio

The acquisitions suggest that Inscripta has shifted its focus to biomanufacturing following dozens of layoffs across two site closures in December.

Agbio Gene Editing Firm Cibus to Merge With Plant Synbio Company Calyxt

The newly merged company will retain the Cibus name and trade on the Nasdaq Capital Market, where Calyxt is currently listed.

Pierian, Seven Bridges, UgenTec Acquired, Merged to Become Velsera

The three firms were acquired by investment fund Summa Equity and merged to form a new Boston-headquartered company.

Scipher Medicine Buys Software Firm CrossBridge

Precision immunology firm Scipher said the acquisition of Philadelphia-based CrossBridge is intended to strengthen its data management and analytics capabilities.

Jan 5, 2023

Macroeconomic Worries Lead to More Subdued Omics, MDx M&A Activity in 2022
Premium

Jan 4, 2023

Moderna to Acquire Japan's OriCiro Genomics for $85M

Jan 4, 2023

Agilent Technologies Acquires NGS Target Enrichment Firm Avida Biomed

Dec 20, 2022

Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M

Dec 5, 2022

European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal

Nov 29, 2022

Bionano Genomics to Acquire Purigen Biosystems for up to $64M

Nov 22, 2022

Biocare Medical Acquires Empire Genomics

Nov 3, 2022

Werfen to Acquire Immucor for $2B

Nov 2, 2022

Myriad Genetics Sees Growth Opportunities on Other Side of Economic Headwinds
Premium

Nov 1, 2022

Myriad Genetics Acquires Gateway Genomics as Q3 Revenues Drop 7 Percent, Miss Estimates

Oct 31, 2022

Thermo Fisher Scientific to Acquire The Binding Site Group for £2.25B in Cash

Oct 27, 2022

Cardio Diagnostics Prepares for New Test Launches Following IPO
Premium

Oct 18, 2022

Patients Choice Laboratories Acquires Texas-Based Infectious Disease MDx Lab

Oct 17, 2022

Clinical Microbiomics Acquires Metabolomics Firm MS-Omics

Oct 14, 2022

DiaCarta to go Public Through SPAC Merger

Oct 10, 2022

Bio-Rad, Qiagen Shares Drop on Report of Possible Merger

Oct 6, 2022

Pluristyx, Pancella, Implant Therapeutics Agree to Merge

Oct 4, 2022

Ginkgo Bioworks Acquires Circularis, Altar

Sep 26, 2022

BioIVT Acquires Biospecimen Firm Fidelis Research

Sep 16, 2022

MDxHealth Plans One-Stop Shop for Prostate Cancer Dx With Acquisition of Oncotype GPS Assay
Premium

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.